When calories and protein are carefully matched in research settings, there is no clinically meaningful fat-loss advantage for low-carbohydrate diets over other dietary patterns
Before getting the results, I suspected that the reality of taking the drugs would be messier than the triumphalist headlines
GLP-1 medications work like an upgraded factory supervisor who coordinates multiple departments at once: Pancreas (Smart Insulin Release): Stimulates insulin only when blood sugar is high stops when sugar normalizes low risk of hypoglycemia (unlike older drugs) Brain (Appetite Control): Acts on hypothalamus & brainstem reduces food cravings food loses emotional grip Stomach (Slow Emptying): Delays gastric emptying smaller meals keep you full longer Liver (Reduced Sugar Output): Suppresses glucagon lowers excessive glucose release from liver improves fasting blood sugar (especially beneficial for insulin-resistant individuals, common in Indian populations) Beyond Blood Sugar (Multi-Organ Effects): GLP-1 receptors found in heart, blood vessels, kidneys, brain being studied for heart failure, kidney disease, fatty liver (NAFLD/NASH), Parkinsons, and Alzheimers GLP-1 Medications List: Names, Forms, and Costs in India (2026) Important note: Oral semaglutide (Rybelsus) is currently approved in India only for Type 2 diabetes, not for weight loss
Cell cycle analysis For cell cycle analysis, cells were fixed in 100% ethanol for 24 h, washed twice with PBS, and then stained for 15 min with PI/RNase staining solution (BD Bioscience Pharmingen)
